International Cannabis Weekly: 178

As 2020 comes to a close, Prohibition Partners’ international team of analysts, consultants and thought-leaders have come together to analyse the top trends set to define the cannabis industry in 2021 and beyond.

From the impact of Brexit and COVID-19, to the rapidly developing legislation in the US and Latin America, here’s what we think the next 12 months have in store for the cannabis industry.

LEARN MORE

HIGHLIGHTS

• APHRIA AND TILRAY ANNOUNCE £2.8B MERGER
• PROHIBITION PARTNERS LIVE THANKS ITS FEATURED SPEAKERS AND SPONSORS

• Irish citizens in possession of cannabis for personal use may avoid criminal charges.
• UK’s first medical cannabis fund, Sapphire Medical Foundation, receives charity status.
• German medical cannabis sales hit €75.5 million in H1 2020.
• Medical cannabis deliveries between the Netherlands and Ireland made permanent.
• NHS to launch patient registry to support medical cannabis research.
• Portugal’s industrial hemp association launches survey on industrial hemp.
• Cannabis innovation could help meet goals of Europe Green Agreement.
• Medical cannabis deliveries between the Netherlands and Ireland made permanent.

A YEAR OF INDUSTRY-LEADING RESEARCH

In 2020, Prohibition Partners published 12 cannabis and psychedelic industry-leading reports.

Our series of reports have provided detailed regional analysis on Europe, Oceania, Latin America and the Caribbean, while our impact series explored the transition of traditional industries including pharmaceuticals, beauty food and drink into cannabis.

Take the opportunity to download our 2020 reports to be fully equipped for the next 12 months.

DOWNLOAD NOW

• New Jersey lawmakers pass measure for an adult-use cannabis marketplace.
• US National Institute of Justice announces US$350,000 grant for efficient THC testing.
• Vermont commences applications for a three-member cannabis control board.
• DEA issues final rule for licensing of cannabis cultivators for research.
• South Carolina lawmakers pre-file Senate bill to legalise medical cannabis.
• US lawmaker introduces bill to lift the THC barrier for hemp to 1.0%.
• Arizona announces draft regulations on adult-use cannabis sales.
• Senate approves cannabis research bill similar to last week’s House measure.
• Colorado state revenue from cannabis sales reaches over US$1.8 billion in 2020.
• Maine medical cannabis sales reach US$222 million from January to October.

WHAT DO YOU WANT TO SEE IN 2021?

Our team has been busy planning an industry-leading content schedule for 2021 and we’re excited to deliver another set of reports which will help the cannabis industry move forward and develop over the next 12 months.

However, we’re eager to understand what you are most interested in seeing from our team next year.

We would like to invite you to fill out this short form, telling us what you would like us to work on in 2021 and be in with the opportunity to win a free version of The Pharmaceutical Cannabis Report (RRP £825).

ENTER TO WIN A FREE COPY OF THE PHARMACEUTICAL CANNABIS REPORT

• Health Canada is concerned too much cannabis is being cultivated at home.
• Aurora reduces production by 25%, leading the company to downsize by 200 employees.
• Legal cannabis sales reach CA$204.3 million in Ontario from July to September.
• Canada launches new consultations on beverages, labelling and research.
• Abba Medix registers more than 500 medical cannabis patients in first-year sales.

• Khiron Life Sciences receives the first legal import of THC cannabis in Peru.
• Brazil postpones evaluation of CBD formulation for medical coverage.
• Around 120 hectares of medicinal cannabis have been planted in Colombia.
• Barbados announces the medicinal cannabis industry will commence in January.
• Avicanna expands into Ecuador and exports first cannabis seeds to Uruguay.
• Bermuda plans a legal framework for adult-use and medical cannabis.
• Brazilian patients struggle to access medical cannabis products.

• Filipino lawmakers file bill to legalise the production and export of medical cannabis.
• Australia announces it will remove the restrictions on the use and sale of low-dose CBD.
• Guam’s Visitors Bureau warns of US$579 million revenue loss due to cannabis.
• New Zealand textile maker nears start-up of hemp production line.
• Australian researchers suggest loosening cannabis research rules.
• Uzbekistan announces regulations and requirements for hemp cultivation.

• South African cannabis grow clubs urge the government to provide clear guidelines.
• Israeli draft law states CBD may only be sold as a food supplement and not in cosmetics.
• Rastafarians in Cape Town march for access to the cannabis industry.
• Israel’s Health Committee discusses plans to legalise cannabis lite.